Dr Anders Hviid is a senior pharmacoepidemiologist who has worked on observational studies of vaccine and drug safety at Statens Serum Institut, Copenhagen, Denmark, since 2001. His research utilises the unique Danish nationwide population registries.
Dr Hviid is responsible for a number of landmark studies on the putative associations between childhood immunisations and serious adverse events such as autism, type 1 diabetes, and non-targeted infections.
A major research interest of his has been the study of vaccine safety in selected populations such as pregnant women and personalised vaccinology. This has resulted in a number of important contributions to the safety of influenza vaccinations in pregnancy and the first genome-wide association study of a vaccine adverse event in the form of febrile seizures.
In addition to his work on vaccine safety, Dr Hviid has also contributed a number of studies on drug safety in pregnancy and cardiovascular adverse events. He is currently the principal investigator of a comprehensive research programme investigating the safety of human papillomavirus vaccination.